Dermatology News

The FDA approved the antibacterial agent oritavancin, making it the third antibiotic approved in 2014 to treat skin infections, according to an agency press release.

Systemic therapy with liposomal amphotericin B resulted in a considerably shorter duration of Leishmania tropica in children than treatment with pentavalent antimony, according to study findings.

Researchers identified four principal skin patterns of manifestation for parvovirus B19: exanthema, acral gloves-and-socks, periflexural and vasculitis, according to a study in the Journal of the American Academy of Dermatology.

The FDA has approved tedizolid for the treatment of acute bacterial skin and skin structure infections, including those caused by MRSA.

Most skin and soft tissue infections are minor and heal on their own or are easily treated without antibiotics, according to new practices guidelines published by the Infectious Diseases Society of America.

Researchers from the University of Pennsylvania suggest that mobile technology to practice teledermatology is feasible for patients with HIV in Botswana.

Efficacy of once-weekly intravenous dalbavancin was comparable to twice-daily intravenous vancomycin for the treatment of acute bacterial skin infections, according to recent trial results.

A single dose of oritavancin was noninferior to a regimen of twice-daily vancomycin given for 7 to 10 days in treating acute bacterial skin infections, according to data from the SOLO I trial.

MRSA rates varied significantly among academic medical centers in California, Illinois, New York and North Carolina, according to study results published in Clinical Infectious Diseases.

Decreased dermal CD4+ cell counts, combined with an increased ratio of CD8+ to CD4+ cells penetrating the dermis, in patients with HIV likely increases the risk for adverse cutaneous drug eruptions like toxic epidermal necrolysis, according to recent study findings.